GeneDx Holdings Corp (NASDAQ:WGS) has a beta value of 2.10 and has seen 1.55 million shares traded in the last trading session. The company, currently valued at $2.67B, closed the last trade at $97.04 per share which meant it gained $7.43 on the day or 8.29% during that session. The WGS stock price is 7.61% off its 52-week high price of $89.66 and 97.11% above the 52-week low of $2.80. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.52 million shares traded. The 3-month trading volume is 626.45K shares.
The consensus among analysts is that GeneDx Holdings Corp (WGS) is Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight.
GeneDx Holdings Corp (NASDAQ:WGS) trade information
Sporting 8.29% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the WGS stock price touched $97.04 or saw a rise of 1.85%. Year-to-date, GeneDx Holdings Corp shares have moved 26.26%, while the 5-day performance has seen it change 26.72%. Over the past 30 days, the shares of GeneDx Holdings Corp (NASDAQ:WGS) have changed 23.07%. Short interest in the company has seen 2.15 million shares shorted with days to cover at 4.09.
Wall Street analysts have a consensus price target for the stock at $45, which means that the shares’ value could drop -115.64% from current levels. The projected low price target is $34.0 while the price target rests at a high of $70.0. In that case, then, we find that the current price level is 27.86% off the targeted high while a plunge would see the stock lose 64.96% from current levels.
GeneDx Holdings Corp (WGS) estimates and forecasts
Figures show that GeneDx Holdings Corp shares have outperformed across the wider relevant industry. The company’s shares have gained 225.53% over the past 6 months, with this year growth rate of 95.38%, compared to 5.10% for the industry.
WGS Dividends
GeneDx Holdings Corp is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
GeneDx Holdings Corp (NASDAQ:WGS)’s Major holders
Insiders own 18.19% of the company shares, while shares held by institutions stand at 72.44% with a share float percentage of 88.55%. Investors are also buoyed by the number of investors in a company, with GeneDx Holdings Corp having a total of 191.0 institutions that hold shares in the company. The top two institutional holders are CASDIN CAPITAL, LLC with over 3.53 million shares worth more than $92.18 million. As of 2024-06-30, CASDIN CAPITAL, LLC held 13.2482% of shares outstanding.
The other major institutional holder is CORVEX MANAGEMENT LP, with the holding of over 2.47 million shares as of 2024-06-30. The firm’s total holdings are worth over $64.66 million and represent 9.2937% of shares outstanding.
